These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30730381)

  • 21. Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
    Tan BH; Low JG; Chlebicka NL; Kurup A; Cheah FK; Lin RT; Goh YT; Wong GC
    Int J Infect Dis; 2011 May; 15(5):e350-6. PubMed ID: 21397541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical feature, image findings and outcome of hepatosplenic candidiasis in patients with acute myeloid leukemia.
    Chang H; Kuo MC; Tang TC; Lin TL; Wu JH
    Biomed J; 2021 Dec; 44(6 Suppl 2):S252-S257. PubMed ID: 35292266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention and treatment of invasive fungal diseases in neutropenic patients.
    Almyroudis NG; Segal BH
    Curr Opin Infect Dis; 2009 Aug; 22(4):385-93. PubMed ID: 19506476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatosplenic candidiasis in patients with acute leukaemia.
    Sallah S; Semelka RC; Wehbie R; Sallah W; Nguyen NP; Vos P
    Br J Haematol; 1999 Sep; 106(3):697-701. PubMed ID: 10468858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risks and outcome of fungal infection in neutropenic children with hematologic diseases.
    Aytaç S; Yildirim I; Ceyhan M; Cetin M; Tuncer M; Kara A; Cengiz AB; Seçmeer G; Yetgin S
    Turk J Pediatr; 2010; 52(2):121-5. PubMed ID: 20560245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
    Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
    Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response of Symptomatic Persistent Chronic Disseminated Candidiasis to Corticosteroid Therapy in Immunosuppressed Pediatric Patients: Case Study and Review of the Literature.
    Shkalim-Zemer V; Levi I; Fischer S; Tamary H; Yakobovich J; Avrahami G; Gilad G; Elitzur S; Yaniv I; Elhasid R; Manistersky M; Shalit I
    Pediatr Infect Dis J; 2018 Jul; 37(7):686-690. PubMed ID: 29140934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005-2013.
    Sahbudak Bal Z; Yilmaz Karapinar D; Karadas N; Sen S; Onder Sivis Z; Akinci AB; Balkan C; Kavakli K; Vardar F; Aydinok Y
    Mycoses; 2015 Apr; 58(4):225-32. PubMed ID: 25728069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nosocomial fungal infections, analysis of 149 cases].
    Liu ZY; Sheng RY; Li XL; Li TS; Wang AX
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):399-402. PubMed ID: 12820917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatosplenic candidiasis in the era of new antifungal drugs: a study in Paris 2000-2007.
    De Castro N; Mazoyer E; Porcher R; Raffoux E; Suarez F; Ribaud P; Lortholary O; Molina JM
    Clin Microbiol Infect; 2012 Jun; 18(6):E185-7. PubMed ID: 22458883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications.
    Anttila VJ; Elonen E; Nordling S; Sivonen A; Ruutu T; Ruutu P
    Clin Infect Dis; 1997 Mar; 24(3):375-80. PubMed ID: 9114188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic systemic (hepatosplenic) candidiasis in a patient with granulocytic sarcoma.
    Gangadharan VP; Sasidharan K; Preetha S; Chithrathara K
    Am J Clin Oncol; 2000 Dec; 23(6):562-3. PubMed ID: 11202796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatosplenic candidiasis in children with cancer. Three cases in leukemic children and a literature review.
    Carstensen H; Widding E; Storm K; Ostergaard E; Herlin T
    Pediatr Hematol Oncol; 1990; 7(1):3-12. PubMed ID: 2204407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatosplenic fungal abscesses in the immunocompromised].
    Gross E; Or R; Weinberger M; Abu-Dalu K; Schiller M
    Harefuah; 1995 Mar; 128(5):271-3, 336. PubMed ID: 7744345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fungal infections in leukemic patients: our experience during 5 years].
    Torre MA; Escalante R; López Martín JC; de la Maya MD; Martínez Estéfano E; López Lacomba D; González Aza C
    Sangre (Barc); 1996 Oct; 41(5):395-7. PubMed ID: 9026926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for hepatosplenic abscesses in patients with acute leukemia receiving empiric azole treatment.
    Chubachi A; Miura I; Ohshima A; Nishinari T; Nimura T; Niitsu H; Miura AB
    Am J Med Sci; 1994 Dec; 308(6):309-12. PubMed ID: 7985717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged fever and splenic lesions caused by Malassezia restricta in an immunocompromised patient.
    de St Maurice A; Frangoul H; Coogan A; Williams JV
    Pediatr Transplant; 2014 Dec; 18(8):E283-6. PubMed ID: 25187171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Invasive hepatosplenic hyalohyphomycosis. Report of a case].
    Pilleux L; Ponticas M; Carrasco C; León A; Salas P; Rodríguez C; Caorsi I
    Rev Med Chil; 2000 Jun; 128(6):641-6. PubMed ID: 11016064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Meropenem therapy in children with febrile neutropenia].
    Müller J; Kovács G; Garami M; Schmidt M; Fekete G
    Orv Hetil; 2003 Oct; 144(43):2115-20. PubMed ID: 14661443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors predicting outcome in high risk febrile neutropenia in patients receiving intensive chemotherapy for acute sleukemia: A prospective, observational study from South India.
    Rajendranath R; Balasubramaniyum VK; Vijayakumar V; Ganesan P; Tenali GS
    Indian J Cancer; 2014; 51(4):481-6. PubMed ID: 26842171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.